Converge Bio raises $25M Series A — 4.5x protein yields, Bessemer + Meta/OpenAI/Wiz execs back it
·TechCrunch
Converge Bio closed a $25M oversubscribed Series A led by Bessemer Venture Partners with TLV Partners, Saras Capital and Vintage Investment Partners participating; execs from Meta, OpenAI and Wiz joined as individual LPs. The company builds generative models trained on DNA, RNA and protein sequence data, with three commercial systems: antibody design, protein yield optimization, and biomarker/target discovery. Traction: 40+ programs with over a dozen pharma/biotech customers across the US, Canada, Europe and Israel, expanding into Asia. Case studies include a 4-to-4.5x protein-yield boost in a single computational pass, and antibodies with single-nanomolar binding affinity. Headcount grew from 9 in Nov 2024 to 34 today. Prior seed was $5.5M in 2024. CEO Dov Gertz founded the company.
startupsdrug-discoverybessemerseries-abiotech
Why it matters
Converge Bio is the cleanest post-GPT-Rosalind signal that the AI-for-biology stack is beginning to bifurcate: OpenAI goes broad and regulated, specialist startups go deep on a single pipeline step (antibody design, yield optimization) with direct pharma contracts. Bessemer backing plus on-paper execs from Meta, OpenAI and Wiz suggest the network is choosing to place bets on vertical AI biotech rather than general-purpose LLM wrappers. 34 employees and 40 programs is unusually productive for a Series A — the efficiency argument for AI-native biotech now has live numbers.
X / Twitter1,800 mentions @BessemerVP · 1,200 likes
Reddit420 upvotes r/startups
r/startups, r/venturecapital
Trust check
high
TechCrunch first-party interview with CEO Dov Gertz, specific investor names, specific case-study numbers (4-4.5x yield, single-nanomolar affinity). Unverified but plausible; no FUD flags.
Kronos (AAAI 2026 accepted, arxiv 2508.02739) is the first open-source foundation model pre-trained on financial candlestick (K-line) sequences. A specialized tokenizer quantizes multi-dimensional OHLCV data into hierarchical discrete tokens; a decoder-only autoregressive transformer is pre-trained on 12B (12 billion) K-line records from 45 global exchanges. Results against the leading time-series foundation model (TSFM) and best non-pretrained baseline: 93% higher RankIC on price-series forecasting over TSFM and 87% over the non-pretrained baseline; 9% lower MAE on volatility forecasting; 22% improvement in generative fidelity for synthetic K-line sequences. Model, weights, and demo are open on GitHub (shiyu-coder/Kronos) — repo is currently GitHub-trending.
Google Research published Simula in Transactions on Machine Learning Research (April 16, 2026): a framework that reframes synthetic data generation as mechanism design, using reasoning-driven construction rather than sample-level optimization. The team (Tim R. Davidson, Benoit Seguin, Enrico Bacis, Cesar Ilharco, Hamza Harkous) generated datasets of up to 512K (512,000) data points across five domains — cybersecurity (CTI-MCQ, CTI-RCM), legal reasoning (LEXam), math (GSM8k), and multilingual knowledge (Global MMLU). Results show 'better data scales better': a 10% accuracy gain on math reasoning using Gemini 2.5 Flash as teacher and Gemma-3 4B as student. The four-step recipe is global diversification → local diversification → complexification → quality checks. Complexification helped math but hurt legal reasoning — the paper warns mechanism design is domain-dependent.
coleam00/Archon is a TypeScript open-source workflow harness that makes AI coding deterministic and repeatable through YAML-defined development processes. Hit 18.8k GitHub stars and is trending weekly. Latest release v0.3.6 on April 12, 2026 with 1,265 commits on dev branch. It ships 17 default workflows covering issue fixes, feature development, PR reviews, and refactoring. Core features: isolated execution (each run gets its own git worktree for parallel conflict-free processing), composable workflows (mix deterministic nodes like bash/tests/git with AI-powered steps like planning/code-gen/review), multi-platform (CLI, Web UI, Slack, Telegram, Discord, GitHub webhooks), and human gates (interactive approval steps). MIT licensed, requires Bun + Claude Code + GitHub CLI.